Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
M Todaro1, Y Lombardo, M G Francipane
1Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy.
Abstract:
We investigated the mechanisms involved in the resistance to cell death observed in epithelial cancers. Here, we identify that primary epithelial cancer cells from colon, breast and lung carcinomas express high levels of the antiapoptotic proteins PED, cFLIP, Bcl-xL and Bcl-2. These cancer cells produced interleukin-4 (IL-4), which amplified the expression levels of these antiapoptotic proteins and prevented cell death induced upon exposure to TRAIL or other drug agents. IL-4 blockade resulted in a significant decrease in the growth rate of epithelial cancer cells and sensitized them, both in vitro and in vivo, to apoptosis induction by TRAIL and chemotherapy via downregulation of the antiapoptotic factors PED, cFLIP, Bcl-xL and Bcl-2. Furthermore, we provide evidence that exogenous IL-4 was able to upregulate the expression levels of these antiapoptotic proteins and potently stabilized the growth of normal epithelial cells rendering them apoptosis resistant. In conclusion, IL-4 acts as an autocrine survival factor in epithelial cells. Our results indicate that inhibition of IL-4/IL-4R signaling may serve as a novel treatment for epithelial cancers.
Insights
Epithelial cancers resist cell death by producing interleukin-4 (IL-4), which boosts anti-apoptotic proteins. Blocking IL-4 reduces cancer growth and increases sensitivity to treatments by lowering these proteins.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Epithelial cancers exhibit resistance to cell death.
- Key anti-apoptotic proteins like PED, cFLIP, Bcl-xL, and Bcl-2 are implicated in this resistance.
Purpose of the Study:
- To investigate the role of interleukin-4 (IL-4) in mediating resistance to cell death in epithelial cancers.
- To explore the potential of targeting IL-4 signaling as a therapeutic strategy.
Main Methods:
- Analysis of anti-apoptotic protein expression in primary colon, breast, and lung carcinoma cells.
- Assessment of IL-4 production and its effect on cell death pathways.
- Evaluation of IL-4 blockade's impact on cancer cell growth and apoptosis induction in vitro and in vivo.
Main Results:
- Epithelial cancer cells express high levels of PED, cFLIP, Bcl-xL, and Bcl-2.
- IL-4 amplifies these anti-apoptotic proteins, preventing TRAIL- or drug-induced cell death.
- IL-4 blockade significantly decreases cancer cell growth and sensitizes cells to apoptosis by downregulating these proteins.
- Exogenous IL-4 promotes apoptosis resistance in normal epithelial cells.
Conclusions:
- IL-4 functions as an autocrine survival factor in epithelial cells.
- Inhibition of IL-4/IL-4R signaling represents a potential novel therapeutic approach for epithelial cancers.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Tumor Immunotherapy
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Apoptosis
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

